Rivaroxaban 15 mg Tablet | ROXARIVABEN 15

Description

ROXARIVABEN 15 is a potent anticoagulant formulation containing Rivaroxaban 15 mg as its active ingredient. Rivaroxaban is a direct Factor Xa inhibitor, which plays a vital role in preventing and managing blood clot formation. This medication is primarily indicated for reducing the risk of stroke and systemic embolism in individuals with nonvalvular atrial fibrillation. It is also used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). With its once-daily dosage, ROXARIVABEN 15 offers a convenient and reliable anticoagulation solution for patients prone to thromboembolic events. Indications / Uses of ROXARIVABEN 15: Prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). Prevention of recurrence of DVT and PE. Prevention of venous thromboembolism (VTE) in patients undergoing hip or knee replacement surgery. Active Ingredient: Rivaroxaban 15 mg: A selective Factor Xa inhibitor that blocks a crucial step in the blood coagulation cascade, thereby effectively reducing the risk of clot formation. Key Benefits: Potent Anticoagulant Action: Effectively manages and prevents thromboembolic conditions. Convenient Once-Daily Dosing: Enhances treatment compliance and ease of use. Stroke Risk Reduction: Lowers the chances of stroke in patients with atrial fibrillation (nonvalvular). DVT & PE Protection: Useful in both initial treatment and preventing future episodes. Clinically Proven: Backed by extensive research and clinical studies demonstrating its efficacy and safety. Mechanism of Action: Rivaroxaban inhibits Factor Xa, a key enzyme responsible for converting prothrombin into thrombin, a major catalyst in the formation of blood clots. By blocking this pathway, it interrupts the clotting process, preventing the conversion of fibrinogen into fibrin, and thus reducing the likelihood of thromboembolic complications such as DVT, PE, and stroke. Possible Side Effects: While generally well-tolerated, ROXARIVABEN 15 may cause: Bleeding (including nosebleeds or gastrointestinal bleeding) Anemia Nausea Dizziness Headache Safety Precautions: Medical Consultation: Inform your doctor about any pre-existing conditions, ongoing treatments, or bleeding disorders before starting this medication. Bleeding Surveillance: Monitor for signs of excessive or unusual bleeding (e.g., easy bruising, blood in urine/stools, prolonged bleeding from cuts). Limit Risky Activities: Avoid contact sports or activities that may lead to injury while on this medication. Pregnancy and Nursing: Seek medical advice before use during pregnancy or breastfeeding. Strict Dosage Compliance: Take the medication exactly as directed. Do not increase or skip doses without medical guidance.